BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20307151)

  • 1. The marketing of pharmaceutical agents: friend or foe?
    Jurd S
    Australas Psychiatry; 2010 Apr; 18(2):97-100. PubMed ID: 20307151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical marketing: nurses are also targeted.
    Prescrire Int; 2010 Aug; 19(108):190. PubMed ID: 20939464
    [No Abstract]   [Full Text] [Related]  

  • 4. Nurse practitioners' perceptions and participation in pharmaceutical marketing.
    Crigger N; Barnes K; Junko A; Rahal S; Sheek C
    J Adv Nurs; 2009 Mar; 65(3):525-33. PubMed ID: 19222650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
    Harris G
    N Y Times Web; 2006 Jan; ():A14. PubMed ID: 16450472
    [No Abstract]   [Full Text] [Related]  

  • 9. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quiz on "the ethics of accepting gifts from industry".
    Holm RP;
    S D Med; 2007 Mar; 60(3):117-8. PubMed ID: 17455581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
    Berger JT
    Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
    [No Abstract]   [Full Text] [Related]  

  • 12. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical student views on interactions with pharmaceutical representatives.
    Ganzini L; Chen Z; Peters D; Misra S; Macht M; Osborne M; Keepers G
    Acad Psychiatry; 2012 May; 36(3):183-7. PubMed ID: 22751818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and provider attitudes toward free drug samples in psychiatric practice.
    Segraves RT; Balon R
    J Clin Psychopharmacol; 2007 Dec; 27(6):732-3. PubMed ID: 18004157
    [No Abstract]   [Full Text] [Related]  

  • 15. Crackdown urged on doc gifts.
    Robeznieks A
    Mod Healthc; 2008 May; 38(18):20. PubMed ID: 18557478
    [No Abstract]   [Full Text] [Related]  

  • 16. Unhealthy drug donations.
    Dabade G
    Indian J Med Ethics; 2004; 1(1):18. PubMed ID: 16370063
    [No Abstract]   [Full Text] [Related]  

  • 17. Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry.
    Hagen B; Pijl-Zieber EM; Souveny K; Lacroix A
    Can Nurse; 2008 Apr; 104(4):30-5. PubMed ID: 18488765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high cost of free lunch.
    Wall LL; Brown D
    Obstet Gynecol; 2007 Jul; 110(1):169-73. PubMed ID: 17601912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug reps and the academic medical center: a case for management rather than prohibition.
    Huddle TS
    Perspect Biol Med; 2008; 51(2):251-60. PubMed ID: 18453729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.